Major Pharmaceuticals Levothyroxine Sodium Tablets, USP Recall (October 2026)
Announced 2026-07-29 · FDA
Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets, USP due to subpotent drug. Lot N02200 with expiration date 10/2026 was distributed nationwide in the USA. The recall is announced by the FDA.
| Brand | Major Pharmaceuticals |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61 |
| Reason | Subpotent Drug |
| Severity | moderate |
| Units affected | N/A |
| Distribution | Nationwide in the USA. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check if you have Lot N02200 tablets and note the expiration date 10/2026.
- Do not use any recalled tablets.
- Return the recalled tablets to your pharmacy or dispose of them according to local guidelines.
- Contact your healthcare provider for guidance on replacement therapy if needed.
How to identify the recalled item
| Lot / date codes | Lot #: N02200, Exp. Date 10/2026 |
|---|---|
| Lot / date codes | Bag lot #: N02172A, N02172B, Exp. Date 07/2026; N02288A, N02288B, Exp. Date 12/2026; Blister lot #: N02172, Exp. Date 07/2026; N02288, Exp. Date 12/2026 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.